Paediatric nutrition risk scores in clinical practice: children with inflammatory bowel disease

A E Wiskin1, D R Owens, V R Cornelius

  • 1NIHR Biomedical Research Unit (Nutrition, Diet & Lifestyle), Southampton, UK.

Insights

Nutrition screening tools show varied agreement in children with inflammatory bowel disease. Some tools may underestimate malnutrition risk, highlighting the need for careful assessment in chronic pediatric conditions.

Area of Science:

  • Pediatric Nutrition
  • Clinical Assessment
  • Gastroenterology

Background:

  • Growing interest in pediatric nutrition risk assessment tools for identifying children needing nutritional support.
  • Limited data exists on the clinical application and inter-tool agreement of non-disease-specific screening tools.

Purpose of the Study:

  • To examine the concurrent validity of four pediatric nutrition screening tools.
  • To assess the agreement between different tools and anthropometric measures of malnutrition in children with inflammatory bowel disease.

Main Methods:

  • Evaluated four nutrition screening tools: STAMP, STRONGkids, PYMS, and PNRS.
  • Assessed 46 children diagnosed with inflammatory bowel disease.
  • Determined malnutrition severity using anthropometry and ICD-10 criteria.

Main Results:

  • Good agreement observed between STAMP, STRONGkids, and PNRS (kappa > 0.6).
  • Modest agreement (kappa = 0.3) between PYMS and other scores; PYMS identified 23 children at low risk, unlike other tools.
  • No agreement between screening tools and anthropometric malnutrition (kappa < 0.1); only 3 children with anthropometric malnutrition were scored high risk.

Conclusions:

  • The clinical relevance of current nutrition screening tools for children with chronic diseases like IBD remains uncertain.
  • Potential exists to under-recognize nutritional impairment and risk in pediatric inflammatory bowel disease patients.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...